Risk of Gadolinium-Based Contrast Agents in Chronic Kidney Disease-Is Zero Good Enough?

JAMA Intern Med. 2020 Feb 1;180(2):230-232. doi: 10.1001/jamainternmed.2019.5278.

Authors

Saugar Maripuri^{1

2}, Kirsten L Johansen^{1

2}

Affiliations

¹ Division of Nephrology, Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota.
² Department of Medicine, University of Minnesota, Minneapolis.

PMID: 31816006
DOI: 10.1001/jamainternmed.2019.5278

No abstract available

Publication types

Comment

MeSH terms

Contrast Media
Gadolinium
Humans
Magnetic Resonance Imaging
Nephrogenic Fibrosing Dermopathy*
Renal Insufficiency, Chronic*

Substances

Contrast Media
Gadolinium